HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preoperative prognostic nutritional index and systemic immune-inflammation index predict survival outcomes in osteosarcoma: A comparison between young and elderly patients.

AbstractOBJECTIVE:
This retrospective study of patients with osteosarcoma investigated the following biomarkers of inflammation and nutritional status: neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, prognostic nutritional index (PNI), and systemic immune-inflammation index (SII). The efficacies of these indicators to predict overall survival (OS) of young and elderly patients were compared.
METHODS:
The data of 125 patients with osteosarcoma, comprising the young (≤20 years) and elderly (60-80 years), were reviewed. Receiver operating characteristic (ROC) curves were calculated to determine the optimal cut-off value and area under the ROC curve of each potential biomarker. Kaplan-Meier curves and a Cox proportional hazards model were used to perform survival analyses.
RESULTS:
The cut-off values for low and high PNI ( ≤48.5, >48.5) and low and high SII (≤607.3, >607.3) were determined. Osteosarcoma patients in low PNI group or high SII group exhibited poorer OS relative to those in high PNI or low SII groups. The univariate and multivariate analyses indicated that preoperative PNI and SII were independent prognostic factors for OS in both the young and elderly subjects.
CONCLUSION:
Preoperative PNI and SII can be viable biomarkers of prognosis for both young and elderly patients with osteosarcoma. Awareness of these valuable indexes will enable clinicians to evaluate the inflammatory and nutritional status of these patients and establish a framework for individualized therapy.
AuthorsCong Ma, Ronghui Yu, Junhong Li, Jingjing Guo, Jianyun Xu, Xiaoyan Wang, Ping Liu
JournalJournal of surgical oncology (J Surg Oncol) Vol. 125 Issue 4 Pg. 754-765 (Mar 2022) ISSN: 1096-9098 [Electronic] United States
PMID34811745 (Publication Type: Comparative Study, Journal Article)
Copyright© 2021 Wiley Periodicals LLC.
Chemical References
  • Biomarkers, Tumor
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Biomarkers, Tumor (analysis)
  • Blood Platelets (pathology)
  • Bone Neoplasms (drug therapy, immunology, mortality, pathology)
  • Female
  • Follow-Up Studies
  • Humans
  • Inflammation (drug therapy, immunology, mortality, pathology)
  • Lymphatic Metastasis
  • Lymphocytes (pathology)
  • Male
  • Middle Aged
  • Neoadjuvant Therapy (mortality)
  • Neoplasm Recurrence, Local (drug therapy, immunology, mortality, pathology)
  • Neutrophils (pathology)
  • Nutrition Assessment
  • Osteosarcoma (drug therapy, immunology, mortality, secondary)
  • Preoperative Care
  • Prognosis
  • ROC Curve
  • Retrospective Studies
  • Survival Rate
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: